R. Marron

ORCID: 0000-0002-7959-8492
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Transplantation: Methods and Outcomes
  • Respiratory Support and Mechanisms
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Tracheal and airway disorders
  • Airway Management and Intubation Techniques
  • Organ Transplantation Techniques and Outcomes
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • COVID-19 Clinical Research Studies
  • Lung Cancer Diagnosis and Treatment
  • Venous Thromboembolism Diagnosis and Management
  • Renal Transplantation Outcomes and Treatments
  • Pulmonary Hypertension Research and Treatments
  • Medical Imaging and Pathology Studies
  • Social Media in Health Education
  • Infection Control and Ventilation
  • Cytomegalovirus and herpesvirus research
  • COVID-19 and healthcare impacts
  • Atrial Fibrillation Management and Outcomes
  • Nosocomial Infections in ICU
  • Polyomavirus and related diseases
  • Long-Term Effects of COVID-19
  • Asthma and respiratory diseases
  • Occupational exposure and asthma
  • Pneumothorax, Barotrauma, Emphysema
  • Viral-associated cancers and disorders

Temple University
2017-2022

Temple University Hospital
2020-2021

Invasive mechanical has been associated with high mortality in COVID-19. Alternative therapy of flow nasal (HFNT) greatly debated around the world for use COVID-19 pandemic due to concern increased healthcare worker transmission.This was a retrospective analysis consecutive patients admitted Temple University Hospital Philadelphia, Pennsylvania, from 10 March 2020 24 April moderate-to-severe respiratory failure treated HFNT. Primary outcome prevention intubation. Of 445 COVID-19, 104 met our...

10.1136/bmjresp-2020-000650 article EN cc-by-nc BMJ Open Respiratory Research 2020-08-01

Virtual bronchoscopic navigation (VBN) with fused fluoroscopy and vessel mapping provides a point of entry (POE) for puncturing airway wall to biopsy lesions. The study was designed evaluate the safety efficacy this technology diagnose peripheral pulmonary lesions.It prospective, single-arm, multicentre study. Patients underwent lesions Archimedes® VBN System via POE using one two techniques: (1) transparenchymal nodule access (BTPNA) (2) guided transbronchial needle aspiration (TBNA)....

10.1111/resp.14224 article EN cc-by-nc-nd Respirology 2022-02-25

Beta-blockers are commonly prescribed for patients with cardiovascular disease. Providers have been wary of treating chronic obstructive pulmonary disease (COPD) beta-blockers due to concern bronchospasm, but retrospective studies shown that cardio-selective safe in COPD and possibly beneficial. However, these benefits may reflect symptom improvements the cardiac effects medication. The purpose this study is evaluate associations between beta-blocker use both exacerbation rates longitudinal...

10.1186/s12931-017-0609-7 article EN cc-by Respiratory Research 2017-06-19

The use of high-flow nasal therapy (HFNT) to treat COVID-19 pneumonia has been greatly debated around the world due concerns about increased health care worker transmission and delays in invasive mechanical ventilation (IMV). Herein, we analyzed utility noninvasive ROX (ratio oxygen saturation) index predict need for timing IMV.This study aimed assess whether can be a useful score intubation IMV patients receiving HFNT as treatment COVID-19-related hypoxemic respiratory failure.This is...

10.2196/29062 article EN cc-by JMIRx Med 2021-06-04

Abstract Use of high flow nasal therapy (HFNT) to treat COVID-19 pneumonia has been greatly debated around the world due concern for increased healthcare worker transmission and delays in invasive mechanical Ventilation (IMV). Methods A retrospective analysis consecutive patients admitted Temple University Hospital Philadelphia, Pennsylvania, from March 10, 2020, May 17, 2020 with moderate severe respiratory failure treated High Flow (HFNT). HFNT were divided into two groups: only progressed...

10.1101/2020.06.30.20143867 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-07-02

Comorbid disease is a risk factor for severe coronavirus 2019 (COVID-19) infection. However, initial rates of chronic obstructive pulmonary (COPD) in case series were low and severity COVID-19 COPD patients was variable.We performed retrospective study admitted with evaluated outcomes those without and/or emphysema. Patients identified as having if they had diagnosis the medical record history airflow-obstruction on spirometry, or tobacco use prescribed long-acting bronchodilator(s)....

10.15326/jcopdf.2020.0200 article EN Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation 2021-01-01

Introduction Use of high flow nasal therapy (HFNT) to treat COVID-19 pneumonia has been greatly debated around the world due concern for increased healthcare worker transmission and delays in invasive mechanical Ventilation (IMV). Herein we analyze utility ROX index predict need timing IMV a retrospective analysis patients with moderate severe hypoxemic respiratory failure treated HFNT. Methods This was 129 consecutive admitted Temple University Hospital Philadelphia, Pennsylvania, from...

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2624 article EN 2021-05-01

Abstract Invasive mechanical has been associated with high mortality in COVID-19. Alternative therapy of High flow nasal (HFNT) greatly debated around the world for use COVID-19 pandemic due to concern increased healthcare worker transmission. Methods This was a retrospective analysis consecutive patients admitted Temple University Hospital Philadelphia, Pennsylvania, from March 10, 2020, April 24, 2020 moderate severe respiratory failure treated Flow (HFNT). Primary outcome prevention...

10.1101/2020.05.22.20109355 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2020-05-26

Section:ChooseTop of pageAbstract <<Key PointsCardiovascular and Neuroc...OSA: New Advances in Posi...OSA: Update on Current No...Controversies Consens...Practical Approaches to C...Risks Management L...Tetrahydrocannabinol, Can...References

10.34197/ats-scholar.2020-0017re article EN cc-by-nc-nd ATS Scholar 2020-12-01

10.15326/jcopdf.6.2.2018.0169 article EN Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation 2019-01-01

Airway complications after lung transplantation are a major cause of morbidity and mortality. Bronchial dehiscence presents within month is typically diagnosed radiographically as sentinel gas pocket at the anastomotic site confirmed with bronchoscopy. A 66-year-old man idiopathic pulmonary fibrosis who underwent right 4 weeks prior developed chest pain palpable crepitus over his wall. X-ray revealed subcutaneous emphysema small right-sided pneumothorax. Computed tomography (CT) thorax...

10.1155/2020/8830361 article EN cc-by Case Reports in Pulmonology 2020-12-26

Rationale: Coronavirus disease 2019 (COVID-19) has provoked an unprecedented global pandemic. Invasive mechanical ventilation (IMV) rates in COVID-19 have been reported to be from 2.3% 33%. The wide range intubation is attributed part diverging institutional practices for the care of patients presenting with hypoxemic respiratory failure. role high flow nasal therapy (HFNT) treatment controversial and underreported. Objectives: To report a retrospective analysis comparing outcomes treated...

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2637 article EN 2021-05-01
Coming Soon ...